Navega Therapeutics, Inc.
Funding history
About Navega Therapeutics, Inc.
How much funding has Navega Therapeutics, Inc. raised?
Navega Therapeutics, Inc. has raised $1.3M in total funding. The most recent round was Series B.
Where is Navega Therapeutics, Inc. headquartered?
Navega Therapeutics, Inc. is headquartered in San Diego, CA.
What problem does Navega Therapeutics, Inc. solve?
Chronic pain currently lacks precise, targeted treatment options.
What's Navega Therapeutics, Inc.'s solution?
Navega Therapeutics develops gene therapies for chronic pain and precision pain management.
What makes Navega Therapeutics, Inc. different?
They specifically harness zinc-finger and CRISPR-based epigenome regulation, technology they position as enabling next-generation, precision gene therapies.
What makes Navega Therapeutics, Inc. notable?
Navega Therapeutics was founded in 2018 by Ana Moreno along with UC San Diego bioengineering professor Prashant Mali, developing gene therapies for chronic pain; it has received a CIRM grant to support its work.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.